Chemicell develops and produces innovative bioseparation- gene transfection and detection systems based on magnetic nano- and microparticles.
Focus of our product development is to design high quality customer-oriented "ready-to use" kits with special orientation towards the compatibility for labor automatisation.
It is chemicell's policy to be open for cooperations with other companies or scientific institutes to maximize the chances and opportunities that evolve from the rapid development of biotechnological procedures and to distribute innovative new products.
Christian Bergemann CEO
Dr. W. Rainer Quaas